about
Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesisMolecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.Safety of targeting tumor endothelial cell antigensCancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapySemaphorin 3A suppresses tumor growth and metastasis in mice melanoma modelWhat can digital transcript profiling reveal about human cancers?Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways.Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective.The Terminal End Bud: the Little Engine that Could.Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.Anti-angiogenic treatment strategies for the therapy of endometriosis.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Building a better TrapEffects of Panax notoginseng on the Metastasis of Human Colorectal Cancer Cells.Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma.Expression of HIF-2alpha/EPAS1 in hepatocellular carcinomaPlants and their active compounds: natural molecules to target angiogenesis.Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment.Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia.Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI.Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis.Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1.Mechanisms of resistance to vascular endothelial growth factor blockade.Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression.Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of miceFusion with human lung cancer cells elongates the life span of human umbilical endothelial cells and enhances the anti-tumor immunity.Antivascular ultrasound therapy: magnetic resonance imaging validation and activation of the immune response in murine melanoma.Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani.Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation.Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.Celastrus orbiculatus extract inhibits tumor angiogenesis by targeting vascular endothelial growth factor signaling pathway and shows potent antitumor activity in hepatocarcinomas in Vitro and in Vivo.The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.Beta 1 integrin is essential for teratoma growth and angiogenesis.The biochemistry of cancer dissemination.Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).Methyl 4-(benz-yloxy)-3-meth-oxy-benzo-ate.An in vitro model for the study of human bone marrow angiogenesis: role of hematopoietic cytokines.
P2860
Q21328694-77787335-01B0-433A-8CAC-2D6D23BF2AFDQ24801047-32184797-4F03-4A06-8A11-7DB8ED0B476FQ26748863-1C81E9A8-EE62-4D67-A409-D3E5C4C48ACBQ26778150-6AA0E055-751C-4387-AC6C-2A29DC1AEF4BQ26824462-88080016-CEC7-4D1E-AFF9-170C3C43D013Q27306612-D524F2BF-7741-4EE4-9368-41125435C891Q30971531-5AD9C82F-47EE-4580-8D7C-F5285EDC792CQ32160506-8A55D4E5-BDCC-4D4C-B6E2-70E57F955354Q33631541-A3B47D91-199A-4E3B-A6FC-928DF0BEC9DBQ33845641-A0A357C8-62DF-4F29-B136-CB4AD6AB017EQ34136521-29CBE55D-A049-4E40-B623-ADE6FB15F6CAQ34283036-98BB2E25-C507-4F64-870B-B75ECC128BBBQ34602545-3D00CE38-C321-4A9D-857A-1423F0914E75Q35170252-A193AB7B-A6C5-4D14-97BA-3F4650ECEA12Q36028764-74063C28-AD84-49D8-8617-9F74CBA413FFQ36309267-2FB94417-6876-4644-9A6A-AE427F09FC8CQ36474296-2218D3AD-0C60-400B-8E64-1DC35F278FEAQ37059810-213A5153-9FB6-4121-9BB9-0E6C8497A2CEQ37201570-14CC1CC9-BD2C-4A86-9A6D-544FD5A71834Q37432062-DFCCCBF4-B7C5-405D-836A-BF82453ABCAEQ37595237-E542963A-B2CC-4759-8D5C-5199E0F9C973Q37828119-1861DA3A-F694-439A-B5AD-380D799F43CAQ37942011-4EA104D0-E58E-457F-805C-D3F6FFC00BB0Q37956587-E27B39D7-9ADF-452A-B2BA-4C83D6A37BC3Q38307072-0EC8615D-A6A5-49FD-9DAF-29278117EE9FQ38697928-ED2E3602-D5C0-4862-9485-4E2101A6A53FQ38857075-0D56460D-54F5-4447-B208-3BB41B8C674CQ38917219-D413CB5C-C37F-4517-968E-96CD38AED859Q38920429-9489FB7B-5AC4-43DC-B323-BC2FD3DCE476Q39085375-4C806DFD-4D54-4608-A7D4-DCB87615B999Q39182427-224FA79D-BF4A-4183-9C98-065B860190A6Q39497289-28CAAB2A-E087-4C19-9DE1-5F07A0E77C3CQ39672736-AD516E6E-B7A4-4D42-A91F-62748C6E1990Q40618771-39401D04-E67F-43FE-B289-4198D79A53D4Q40814241-DF5E1A6E-572F-441D-8E8E-00EE10FDE536Q41089035-F2401C5D-EBA8-4ABF-9EF1-1B129157170FQ41547351-8AC87CC1-344F-4270-8D58-78D091F60E94Q41746287-A6BCAE96-8B1B-45D5-B034-8171C1B39B64Q42121051-9615E967-0035-42DE-B231-CDDAF5B12E9BQ42487150-C6D0383C-3E1A-43B7-B0D9-7AA46228B990
P2860
description
im September 1996 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 1996
@uk
name
Fighting Cancer by Attacking its Blood Supply
@en
Fighting Cancer by Attacking its Blood Supply
@nl
type
label
Fighting Cancer by Attacking its Blood Supply
@en
Fighting Cancer by Attacking its Blood Supply
@nl
prefLabel
Fighting Cancer by Attacking its Blood Supply
@en
Fighting Cancer by Attacking its Blood Supply
@nl
P1433
P1476
Fighting Cancer by Attacking its Blood Supply
@en
P2093
Judah Folkman
P304
P356
10.1038/SCIENTIFICAMERICAN0996-150
P577
1996-09-01T00:00:00Z